These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38791336)

  • 1. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview.
    Araldi RP; Khalil C; Grignet PH; Teixeira MR; de Melo TC; Módolo DG; Fernandes LGV; Ruiz J; de Souza EB
    Gene; 2020 Jun; 745():144636. PubMed ID: 32244056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans.
    Karpov DS
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches.
    Leal AF; Herreno-Pachón AM; Benincore-Flórez E; Karunathilaka A; Tomatsu S
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR Therapy of Sickle Cell Disease: The Dawning of the Gene Editing Era.
    Adashi EY; Gruppuso PA; Cohen IG
    Am J Med; 2024 May; 137(5):390-392. PubMed ID: 38184185
    [No Abstract]   [Full Text] [Related]  

  • 8. Intron Editing Reveals
    Matveeva A; Vinogradov D; Zhuravlev E; Semenov D; Vlassov V; Stepanov G
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".
    Karpov DS; Sosnovtseva AO; Pylina SV; Bastrich AN; Petrova DA; Kovalev MA; Shuvalova AI; Eremkina AK; Mokrysheva NG
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity.
    Abashkin DA; Karpov DS; Kurishev AO; Marilovtseva EV; Golimbet VE
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas Technology for Bioengineering Conventional and Non-Conventional Yeasts: Progress and New Challenges.
    Xia Y; Li Y; Shen W; Yang H; Chen X
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
    Hryhorowicz M; Lipiński D; Zeyland J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients.
    Malahe SRK; van Kampen JJA; Manintveld OC; Hoek RAS; den Hoed CM; Baan CC; Kho MML; Verjans GMGM
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas-mediated plant genome editing: outstanding challenges a decade after implementation.
    Cardi T; Murovec J; Bakhsh A; Boniecka J; Bruegmann T; Bull SE; Eeckhaut T; Fladung M; Galovic V; Linkiewicz A; Lukan T; Mafra I; Michalski K; Kavas M; Nicolia A; Nowakowska J; Sági L; Sarmiento C; Yıldırım K; Zlatković M; Hensel G; Van Laere K
    Trends Plant Sci; 2023 Oct; 28(10):1144-1165. PubMed ID: 37331842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.
    Paschoudi K; Yannaki E; Psatha N
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of DNA targeting CRISPR editors in human cells.
    Huang H; Lv W; Li J; Huang G; Tan Z; Hu Y; Ma S; Zhang X; Huang L; Lin Y
    Cell Biosci; 2023 Jan; 13(1):11. PubMed ID: 36647130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Mouse Phenotyping Consortium: comprehensive knockout phenotyping underpinning the study of human disease.
    Groza T; Gomez FL; Mashhadi HH; Muñoz-Fuentes V; Gunes O; Wilson R; Cacheiro P; Frost A; Keskivali-Bond P; Vardal B; McCoy A; Cheng TK; Santos L; Wells S; Smedley D; Mallon AM; Parkinson H
    Nucleic Acids Res; 2023 Jan; 51(D1):D1038-D1045. PubMed ID: 36305825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Modifications of CRISPR RNAs to Improve Gene-Editing Activity and Specificity.
    Rozners E
    J Am Chem Soc; 2022 Jul; 144(28):12584-12594. PubMed ID: 35796760
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.